US Stock MarketDetailed Quotes
BIOA BioAge Labs
- 20.170
- +0.170+0.85%
Close Nov 13 16:00 ET
- 20.080
- -0.090-0.45%
Post 20:02 ET
723.07MMarket Cap-9725P/E (TTM)
21.500High20.000Low223.90KVolume20.000Open20.000Pre Close4.61MTurnover2.13%Turnover RatioLossP/E (Static)35.85MShares26.62052wk High2.30P/B211.79MFloat Cap18.30052wk Low--Dividend TTM10.50MShs Float26.620Historical High--Div YieldTTM7.50%Amplitude18.300Historical Low20.591Avg Price1Lot Size
About BioAge Labs Company
BioAge Labs, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapeutic products for metabolic diseases, such as obesity, by targeting the biology of human beings. It offers Azelaprag, a potential oral therapeutic for obesity, followed by several earlier-stage metabolic programs. The company was founded by Kristen Fortney and Eric Morgen on April 1, 2015 and is headquartered in Richmond, CA.
Company Profile
SymbolBIOA
Company NameBioAge Labs
Listing DateSep 26, 2024
Issue Price18.00
Founded2015
CEODr. Kristen Fortney, PhD
MarketNASDAQ
Employees60
Fiscal Year Ends12-31
Address1445A South 50th Street
CityRichmond
ProvinceCalifornia
CountryUnited States of America
Zip Code94804
Phone1-510-806-1445
Websitehttp://www.bioagelabs.com
Company Executives
- Name
- Position
- Salary
- Dr. Kristen Fortney, PhD
- Chief Executive Officer, President and Director
- 1.38M
- Dr. Paul D. Rubin, M.D.
- Chief Medical Officer
- 840.83K
- Dr. Eric Morgen, M.D.
- Chief Operating Officer and Director
- 872.80K
- Dr. Dov A. Goldstein, M.B.A.,M.D.
- Chief Financial Officer
- --
- Dr. Jean-Pierre Garnier, PhD
- Chairman of the Board
- --
- Rekha Hemrajani, M.B.A.
- Independent Director
- 40.00K
- Dr. Michael Harvey Davidson, M.D.
- Independent Director
- --
- Dr. James I. Healy, M.D.,PhD
- Independent Director
- --
- Patrick G. Enright, M.B.A.
- Independent Director
- --
- Dr. Vijay Pande, PhD
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
